Financial News Feed

Today AAAP ranks # as HOLD CANDIDATE.
Today AAAP ranks # as HOLD CANDIDATE.

AAAP stock Advanced Accelerator Applications S.A.

AAAP stock
Advanced Accelerator Applications S.A.

While CEO Vas Narasimhan is busy boasting Novartis’ new position in radiotherapies built on its 2017 acquisition of Advanced Accelerator Applications, the centerpiece of that buyout, Lutathera—or ...

Read more

Jason Marks appointed Chief Legal Officer / General Counsel Jordan Silverstein appointed Head of Corporate Strategy / Development JENA, Germany and NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- InflaRx ...

Read more

7 December 2018 Anglo African Agriculture plc (“AAAP” or the “Company”) Publication of Prospectus Anglo African Agriculture plc (LSE: AAAP) is pleased to announce that the Prospectus dated 7 D...

Read more

(MENAFN - GlobeNewsWire - Nasdaq) itemprop="articleBody"> Novel small molecule FF-10158 targets integrin alphavbeta3 (avβ3) and alphavbeta5 (avβ5) receptors Expands theragnosti......

Read more

Rebalancing of the FTSE 100 happens four times a year on a Wednesday immediately succeeding the first Friday of the months of March, June, September, and December.Related Symbols: LSE:AAAP...

Read more

As of late, the Street has taken a bit closer look at shares of John Wiley & Sons, Inc. (:JW-A). In the latest session the stock moved -0.76%, putting the stock value at $64.95.Related Symbols: NY...

Read more

SAINT-GENIS-POUILLY, France, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), a Novartis company ......

Read more

Investment company Athos Capital Ltd buys Time Warner Inc, Videocon d2h, Monsanto Co, JA Solar Holdings Co, eHi Car Services, ResMed Inc, Advanced Accelerator Applications SA, SK Telecom Co, NxStage M...

Read more

Just months after picking up Advanced Accelerator Applications in a $3.9 billion buyout, Novartis is getting a quick boost with the U.S. approval for Lutathera....

Read more

Press Release: Novartis: Advanced Accelerator Applications Receives FDA Approval for Lutathera(R) for Treatment of Gastroenteropancreatic Neuroendocrine Tumors | Nachricht | finanzen.net...

Read more

The biotech sector rebounded in 2017, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) rallying more than 21 percent. This follows an ......

Read more

As expected, the board of Advanced Accelerator (AAAP) has determined that Novartis' (NVS) $41/ordinary share offer totaling ~$3.9B is a good thing for the ...

Read more

Novartis Makes a Deal That Should Go Down Easy
05:10pm, Monday, 30'th Oct 2017
The drugmaker’s acquisition of Advanced Accelerator Applications is not coming cheap, but should provide Novartis with a respectable return on its investment....

Read more

The French biotech is being acquired by Novarits....

Read more

Novartis said it has agreed to acquire Advanced Accelerator Applications for $3.9 billion, a deal that would boost its oncology portfolio as generic competition eats into sales of blockbuster blood-ca...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank